// App-Quantinova.ai

3370 : Outcomes In Patients With Acute Lymphoblastic Leukemia In First Or Second Complete Remission Receiving Ex-Vivo T-Cell Depleted Or Unmodified Allografts: Comparison Of Results At Two Institutions

Researchers

Presenter

  • Gabriela Soriano Hobbs

Principal Investigators

  • Patrick Hilden

  • Amir Hamdi

  • Richard E. Champlin

  • Sergio A Giralt

  • Partow Kebriaei

  • Miguel Angel Perales

  • Jenna D Goldberg

  • Michelle Poon

  • Celina Ledesma

  • Sean Devlin

  • Gabriela Rondon

  • Esperanza B. Papadopoulos

  • Ann A. Jakubowski

  • Richard J. -Reilly

Medical Centers

  • Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

  • Pediatric Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Pediatric Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Surgery, Gynecologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

  • National University Singapore Cancer Institute, NA, Singapore

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

Drug/Treatment

  • Methotrexate

  • Tacrolimus

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved